(E)-1-(4-(6-((5-(3,4-Difluorostyryl)thiazol-2-yl)amino)-2-methylpyrimidin-4-yl)piperazin-1-yl)hex-5-yn-1-one

ID: ALA4647144

PubChem CID: 156020260

Max Phase: Preclinical

Molecular Formula: C26H26F2N6OS

Molecular Weight: 508.60

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C#CCCCC(=O)N1CCN(c2cc(Nc3ncc(/C=C/c4ccc(F)c(F)c4)s3)nc(C)n2)CC1

Standard InChI:  InChI=1S/C26H26F2N6OS/c1-3-4-5-6-25(35)34-13-11-33(12-14-34)24-16-23(30-18(2)31-24)32-26-29-17-20(36-26)9-7-19-8-10-21(27)22(28)15-19/h1,7-10,15-17H,4-6,11-14H2,2H3,(H,29,30,31,32)/b9-7+

Standard InChI Key:  PCXCLNAEWVNORT-VQHVLOKHSA-N

Molfile:  

 
     RDKit          2D

 36 39  0  0  0  0  0  0  0  0999 V2000
   31.7560  -24.5015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7697  -23.6867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4892  -23.2907    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.4989  -22.4759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8037  -22.0512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0842  -22.4471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0640  -23.2678    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.3891  -22.0265    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.4089  -21.2120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7037  -20.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9845  -21.1751    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.9746  -21.9957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6750  -22.4196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2894  -20.7545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5752  -21.1475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8743  -20.7238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1602  -21.1169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4633  -20.6933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7641  -20.2727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3060  -19.9397    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.2130  -22.0787    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.2303  -21.2639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5737  -20.7697    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   32.8453  -19.9996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6601  -20.0153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8971  -20.7938    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.3789  -19.3285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7269  -18.5891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2606  -17.9180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6128  -17.1813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1472  -16.5106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3319  -16.5786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9845  -17.3229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4522  -17.9905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1704  -17.3941    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   30.8647  -15.9081    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  2  0
  3  4  1  0
  5  4  2  0
  6  5  1  0
  7  6  2  0
  2  7  1  0
  6  8  1  0
  9  8  1  0
 10  9  1  0
 11 10  1  0
 11 12  1  0
 13 12  1  0
  8 13  1  0
 11 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  3  0
 14 20  2  0
 21  4  1  0
 22 21  1  0
 23 22  1  0
 23 24  1  0
 25 24  2  0
 26 25  1  0
 22 26  2  0
 27 24  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 33 35  1  0
 32 36  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4647144

    ---

Associated Targets(Human)

ABL1 Tclin Cereblon/BCR/ABL (220 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 508.60Molecular Weight (Monoisotopic): 508.1857AlogP: 4.89#Rotatable Bonds: 8
Polar Surface Area: 74.25Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.83CX Basic pKa: 6.49CX LogP: 5.88CX LogD: 5.83
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.35Np Likeness Score: -1.80

References

1. Yang Y, Gao H, Sun X, Sun Y, Qiu Y, Weng Q, Rao Y..  (2020)  Global PROTAC Toolbox for Degrading BCR-ABL Overcomes Drug-Resistant Mutants and Adverse Effects.,  63  (15): [PMID:32657579] [10.1021/acs.jmedchem.0c00967]

Source